EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exosome‐Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges

Husni Farah, Munthar Kadhim-Abosaoda, Hayjaa Mohaisen-Mousa, Renuka Jyothi, Priya Priyadarshini-Nayak iD, Bethanney Janney-J, Gurjant Singh, Ashish Singh-Chauhan, Manoj Kumar-Mishra

Journal of Gastroenterology and Hepatology · 2026-03 · 41 (3) · 863-879

DOI: 10.1111/jgh.70245 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 02.02.2026. Verfasst von Husni Farah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Exosomes, Carcinoma, Hepatocellular, Liver Neoplasms, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 187 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains one of the most prevalent and lethal malignancies worldwide, characterized by late diagnosis, limited therapeutic options, and poor prognosis. Conventional systemic therapies such as sorafenib and its successors provide only modest survival benefits and are frequently complicated by toxicity and drug resistance. In recent years, immunotherapy has emerged as a promising avenue, yet its efficacy is often restricted by the profoundly immunosuppressive tumor microenvironment (TME). Within this landscape, exosomes—nanoscale extracellular vesicles secreted by tumor, stromal, and immune cells—have gained increasing attention for their central role in intercellular communication. They influence immune modulation, metabolic reprogramming, and therapeutic resistance, while also serving as potential biomarkers, nanocarriers, and vaccine platforms. Tumor‐derived exosomes (TEXs) contribute to immune evasion by suppressing CD8 + T cells, polarizing macrophages toward protumoral phenotypes, and enhancing immune checkpoint resistance. Conversely, engineered exosomes demonstrate significant therapeutic potential by reprogramming TAMs, improving drug delivery, and acting as cancer vaccines. Despite these advances, challenges remain in exosome biogenesis, heterogeneity, large‐scale production, and off‐target effects, which hinder clinical translation. Furthermore, interactions between exosomes and gut microbiota in modulating hepatic immunity represent an emerging frontier with unexplored therapeutic implications. Continued advances in bioengineering, nanotechnology, and systems biology are expected to refine exosome‐based therapies, offering novel, personalized strategies to improve outcomes for HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesCarcinoma, HepatocellularLiver NeoplasmsImmunotherapyHumansTumor MicroenvironmentCancer VaccinesAnimals

Stichwörter der Autor:innen

drug deliveryexosomeshepatocellular carcinomaimmunotherapytumor microenvironment

Substanzen

Cancer Vaccines

Autor:innen und Institutionen

  • Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
  • College of Pharmacy, Islamic University, Najaf, Iraq.
  • College of Pharmacy, Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq.
  • Department of Medicinal Chemistry, Al-Turath University, Baghdad, Iraq.
  • Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
  • Department of Medical Oncology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.

ORCID-Profile: Priya Priyadarshini-Nayak

Zitieren

APA

Farah, H., Kadhim-Abosaoda, M., Mohaisen-Mousa, H., Jyothi, R., Priyadarshini-Nayak, P., Janney-J, B., Singh, G., Singh-Chauhan, A., & Kumar-Mishra, M. (2026). Exosome‐Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges. Journal of Gastroenterology and Hepatology, 41(3), 863-879. https://doi.org/10.1111/jgh.70245

Vancouver

Farah H, Kadhim-Abosaoda M, Mohaisen-Mousa H, Jyothi R, Priyadarshini-Nayak P, Janney-J B, et al. Exosome‐Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges. Journal of Gastroenterology and Hepatology. 2026;41(3):863-879. doi:10.1111/jgh.70245

BibTeX
@article{Farah2026,
  author = {Farah, Husni and Kadhim-Abosaoda, Munthar and Mohaisen-Mousa, Hayjaa and Jyothi, Renuka and Priyadarshini-Nayak, Priya and Janney-J, Bethanney and Singh, Gurjant and Singh-Chauhan, Ashish and Kumar-Mishra, Manoj},
  title = {Exosome‐Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {3},
  pages = {863--879},
  doi = {10.1111/jgh.70245}
}
Kostenlos starten →